| 标题 |
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Thomas Powles; Piotr Tomczak; Se Hoon Park; Balaji Venugopal; Thomas Ferguson; et al 出版日期:2022-08-30 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)